Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast carcinoma

Cancer

Volumn 98, Issue 4, 2003, Pages 690-696

  Rietman, Johan S ^a,b   Dijkstra, Pieter U ^a,b   Geertzen, Jan H B ^a,b   Baas, Peter ^c   De Vries, Jaap ^a   Dolsma, Wil ^a   Groothoff, Johan W ^b   Eisma, Willem H ^a   Hoekstra, Harald J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c MARTINI HOSPITAL   (Netherlands)

Author keywords

Activities of daily life; Breast carcinoma; Morbidity; Sentinel lymph node; Staging

Indexed keywords

ADULT; AGED; ARM DISEASE; ARTHROPATHY; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER STAGING; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; GRIP STRENGTH; HUMAN; LIMB PAIN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MORBIDITY; MUSCLE STRENGTH; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

ACTIVITIES OF DAILY LIVING; ARM; AXILLA; BREAST NEOPLASMS; EDEMA; FEMALE; HAND STRENGTH; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; MOVEMENT; PAIN; PROSPECTIVE STUDIES; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY; SHOULDER JOINT;

EID: 0042572499     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11545     Document Type: Article

References (49)

1. Visser O, Coebergh JWW, Schouten LJ, van Dijck JAAM. Incidence of cancer in the Netherlands 1997. Ninth report of the Netherlands Cancer Registry. Utrecht: Netherlands Cancer Registry, 2001.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.
3. Moffat FL, Senofsky GM, Davis K, et al. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol. 1992;51:8-13.
4. Donegan WL. Prognostic factors: stage and receptor status in breast cancer. Cancer. 1992;70:1755-1764.
5. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer. 1983;52:1551-1557.
6. Carter CL, Allen C, Henson DE. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187.
7. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer. 1995;76:1491-1512.
8. Thomson AM, Air M, Jack WJL, Kerr GR, Rodger A, Chetty U. Arm morbidity after breast conservation and axillary therapy. Breast. 1995;4:273-276.
9. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer Stage I. Results from a randomised trial. Eur J Cancer. 1997;33:193-199.
10. Pezner RD, Patterson MP, Hill RL, et al. Arm lymphoedema in patients treated conservatively for breast cancer: relationship to patients age and axillary node dissection techniques. Int J Radiar Oncol Biol Phys. 1986;12:2079-2083.
11. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136-138.
12. Warmuth MA, Bowen G, Pronitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast. Cancer. 1998;83:1362-1368.
13. Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275-286.
14. Rietman JS, Dijkstra PU, Hoekstra HJ, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life; a systematic review. Eur J Surg Oncol. 2003;29:229-238.
15. Swedborg I, Borg G, Sarnelid M. Somatic sensation and discomfort in the arm of post-mastectomy patients. Scand J Rehabil Med. 1981;13:23-29.
16. Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling. Cancer. 1993;72:3248-3253.
17. Maunsell E, Brisson J, Deschènes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg. 1992;36:315-320.
18. Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol. 1999;17:143-149.
19. Ververs JMMA, Roumen RMH, Vingerhoets AJJM, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37:991-999.
20. Poole K, Fallowfield LJ. The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review. Breast. 2002;11:81-87.
21. Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20:4242-4248.
22. Tasmuth T, von Smitten K, Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer. 1996;74:2024-2031.
23. Sakorafas GH, Tsiotou AG, Balsiger BM. Axillary lymph node dissection in breast cancer: current status and controversies, alternative strategies and future perspectives. Acta Oncol. 2000;4:455-466.
24. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-399.
25. Statman RC, Jones RC, Cabot MC, et al. Sentinel lymphadenectomy. A technique to eliminate axillary dissection in node-negative breast cancer [abstract]. Proc Am Soc Clin Oncol. 1996;15:167a.
26. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608-614.
27. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol. 2001; 77:165-170.
28. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349;1864-1867.
29. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748-752.
30. Haid A, Köberle-Wührer R, Knauer M, et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat. 2002;73:31-36.
31. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less post-operative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002;183:23-27.
32. Baron RH, Fey JV, Raboy S, et al. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum. 2002;29:652-659.
33. Temple LKF, Baron R, Cody HS, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002;9:654-662.
34. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 2002;9:745-753.
35. Haid A, Kuehn P, Konstantiniuk R, et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol. 2002;28:705-710.
36. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors, 5th edition, New York: John Wiley & Sons, 1997.
37. Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BB. Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol. 1998;24:316-319.
38. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol. 1992;50:47-52.
39. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986;27: 117-126.
40. Gerber L, Lampert M, Wood C, et al. Comparison of pain, motion and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat. 1992;21:139-145.
41. Green S, Buchbinder R, Forbes A, Bellamy N. A standardized protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res. 1998;11:43-52.
42. Van der Ploeg RJ. Hand-held dynamometry [thesis]. Groningen: University of Groningen, 1992.
43. Van der Ploeg RJ, Fidler V, Oosterhuis HJ. Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry. 1991; 54:244-247.
44. Balogun JA, Powell R, Trullender B, Olson S, Balogun AO. Intra- and inter-tester reliability of the NicholasR hand-held dynamometer during evaluation of upper extremity isometric muscle strength. Eur J Phys Med Rehabil. 1998;8:48-53.
45. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg [Am]. 1984;9:222-226.
46. Van der Heijden GJ. Shoulder disorder treatment: efficacy of ultrasound therapy and electrotherapy [thesis]. Maastricht: University of Maastricht, 1996.
47. Van der Heijden GL, Leffers P, Bouter LM. Shoulder disability questionnaire design and responsiveness of a functional status measure. J Clin Epidemiol. 2000;53:29-38.
48. Kempen GI, Miedema I, Ormel J, Molenaar W. The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med. 1996;43:1601-1610.
49. Suurmeijer TP, Doeglas DM, Moum T, et al. The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health. 1994;84: 170-173.